Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|February 25, 2023
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial CancerSantosh K Dasari, Robiya Joseph, Sujanitha Umamaheswaran, et al.
Cell Reports|February 10, 2021
Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotypeShaolin Ma, Michael H McGuire, Lingegowda S Mangala, et al.
Ebiomedicine|January 19, 2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axisCristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Oncotarget|April 21, 2017
Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAsMohammed H Rashed, Pinar Kanlikilicer, Cristian Rodriguez-Aguayo, et al.
Ebiomedicine|November 30, 2018
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Cancers|September 9, 2022
Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian CarcinomaElaine Stur, Emine Bayraktar, Graziela Zibetti Dal Molin, et al.
Molecular Cancer Therapeutics|September 29, 2021
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse ModelsKatelyn F Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer ModelsPinar Kanlikilicer, Bulent Ozpolat, Burcu Aslan, et al.
International Journal of Molecular Sciences|January 27, 2024
EphA2- and HDAC-Targeted Combination Therapy in Endometrial CancerRobiya Joseph, Santosh K Dasari, Sujanitha Umamaheswaran, et al.
NPJ Precision Oncology|April 25, 2025
The dynamic immune behavior of primary and metastatic ovarian carcinomaElaine Stur, Fuduan Peng, Pang-Ning Teng, et al.
Pageof 5